News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dyax Corp. (DYAX) to Participate in Upcoming 2013 Healthcare Conferences


2/20/2013 6:18:41 AM

Dyax Corp. (NASDAQ: DYAX) announced today that executive management will participate in two upcoming conferences, providing a corporate update regarding the Company’s key value drivers – the KALBITOR®(ecallantide) business and the angioedema portfolio, as well as the Licensing and Funded Research Program (LFRP).

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES